The Neurodegenerative Characteristics of Alzheimer's Disease and Related Multi-Target Drug Design Studies

dc.contributor.authorGulcan, Hayrettin Ozan
dc.contributor.authorOrhan, Ilkay Erdogan
dc.coverage.doi10.1201/9780429295034
dc.date.accessioned2026-02-06T18:19:47Z
dc.date.issued2019
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.endpage504
dc.identifier.isbn978-0-429-29503-4
dc.identifier.isbn978-981-4800-61-7
dc.identifier.orcid0000-0002-7379-5436
dc.identifier.scopusqualityN/A
dc.identifier.startpage473
dc.identifier.urihttps://hdl.handle.net/11129/9269
dc.identifier.volume4
dc.identifier.wosWOS:000626722800013
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherJenny Stanford Publ Pte Ltd
dc.relation.ispartofPharmaceutical Biocatalysis: Fundamentals, Enzyme Inhibitors, and Enzymes in Health and Diseases
dc.relation.publicationcategoryKitap Bölümü - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260204
dc.subjectBeta-Amyloid Aggregation
dc.subjectMonoamine Oxidase Inhibitor
dc.subjectMannich Base Derivatives
dc.subjectTargeting A-Beta
dc.subjectDual Inhibitors
dc.subjectIn-Vitro
dc.subjectAntioxidant Properties
dc.subjectMao-B
dc.subjectCholinesterase Inhibition
dc.subjectAssociation Workgroups
dc.titleThe Neurodegenerative Characteristics of Alzheimer's Disease and Related Multi-Target Drug Design Studies
dc.typeBook Chapter

Files